Pulmonary-artery catheters
This article was originally published in The Gray Sheet
Executive Summary
PACs offer no benefit in guiding major abdominal, thoracic, vascular or hip-fracture surgeries in high-risk elderly patients, according to a study by James Sandham, MD, University of Calgary, et al., published in the Jan. 2 New England Journal of Medicine. The study evaluated mortality in 1,994 elderly patients undergoing major surgery, randomized to groups with and without PACs. Among those whose surgery included a PAC, 7.8% died in the hospital compared with 7.7% of patients treated without it...
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.